Life Chemicals
Life Chemicals supplies high-throughput screening compounds, targeted and fragment libraries, building blocks, and custom synthesis services to pharmaceutical, biotech, and academic research clients globally. Founded in 2004, it produces from Kyiv, Ukraine, with distribution in the USA and Germany.
- Company typePrivate
- Founded2004
- HeadquartersNiagara Falls, Canada
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Life Chemicals does
Life Chemicals is a privately held global supplier of high-throughput screening (HTS) compounds, targeted and focused screening libraries, fragment libraries, building blocks, and custom synthesis services for medicinal chemistry. Founded in 2004, the company is headquartered in Niagara-on-the-Lake/Niagara Falls, Canada, while primary production operations are concentrated in Kyiv, Ukraine, with additional distribution infrastructure in the USA and Germany. Its customer base spans pharmaceutical and biotechnology companies, academic and research institutions (including named accounts MIT and Harvard), and contract research organizations.
The company's product portfolio centers on a curated catalog — an HTS Compound Collection of approximately 419,000 stock compounds, more than 50 targeted and focused screening libraries, fragment libraries, and a catalog of building blocks for medicinal chemistry — augmented by the proprietary LifeCheMyriads Space, which provides virtual access to billions of ready-to-synthesize molecules through cheminformatics-driven selection. AI and machine learning are integrated into screening workflows via machine learning–based ADMET optimization, AI-generated screening compound sets, an AI-enhanced EGFR library, and a formal partnership with Variational AI for generative AI in drug discovery. Peer-reviewed research, including dual-inhibitor work on SARS-CoV-2 proteases published in Current Chemistry Letters (2026), supports scientific visibility. The company also offers compound library management and custom synthesis services as fee-for-science engagements.
Revenue is generated through one-time-license catalog sales of screening compounds and building blocks, plus fee-for-service income from compound library management and custom synthesis contracts. Pricing is quote-based and not publicly disclosed, with deliveries executed on FCA Kyiv terms. SynbiaS operates as a subsidiary in the fine chemicals segment. The company operates with a headcount of approximately 51-100 employees and is not publicly listed.
Life Chemicals firmographics
Firmographics- Name
- Life Chemicals
- Legal name
- Life Chemicals
- Website
- https://lifechemicals.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Life Chemicals supplies high-throughput screening compounds, targeted and fragment libraries, building blocks, and custom synthesis services to pharmaceutical, biotech, and academic research clients globally. Founded in 2004, it produces from Kyiv, Ukraine, with distribution in the USA and Germany.
- Ownership category
- akta.pro rank
Life Chemicals industry classification
Industry- Product category
- Drug Discovery Screening Compounds and Building Blocks
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening) (HLAAAIAA)
- akta.pro secondary industries
- Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries) (HLAAAIAL), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
Keywords
Where Life Chemicals is headquartered
LocationHeadquarters
- HQ city
- Niagara Falls
- HQ country
- Canada
- HQ region
- North America
Offices3 records
Markets served
Life Chemicals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Screening Compound and Library Sales: Sale of HTS compound collections, targeted screening libraries, fragment libraries, and pre-plated sets. Revenue generated from one-time purchases of compounds with recurring customer reorders for hit resupply.
- Building Blocks: Sale of stock and tangible building blocks for synthetic chemistry applications. Both off-the-shelf and synthesized-upon-request options available.
- Compound Library Management Services: Storage, plating, reformatting, cherry-picking, and customized plate mapping services. Provides secure library storage at -40C with global shipment capabilities.
- Custom Synthesis and Contract Research: Custom synthesis services, early drug discovery services, library synthesis, computational chemistry, and analogue search services for pharmaceutical and biotech customers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom quotation-based pricing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Life Chemicals product offering
Product offeringCore offering
Life Chemicals manufactures and supplies high-throughput screening (HTS) compound collections, targeted screening libraries, fragment libraries, covalent inhibitor libraries, and medicinal chemistry building blocks for drug discovery. The company also provides contract research services including custom synthesis, computational chemistry via its LifeCheMyriads Space platform, and compound library management (plating, storage, cherry-picking, worldwide distribution).
Product overview
Life Chemicals operates as a platform-plus-services model offering a comprehensive portfolio of screening compounds, building blocks, and drug discovery services. The core products include the HTS Compound Collection as the foundational screening library, supplemented by 50+ Targeted and Focused Screening Libraries addressing specific therapeutic areas (Alzheimer's, Parkinson's, oncology, antiviral), Fragment Libraries for FBDD, Covalent Inhibitor Libraries, and Pre-plated Screening Sets for assay-ready use. The product line extends to Building Blocks for synthetic chemistry and AI-Generated Screening Compounds designed through generative AI methods. Services include Custom Synthesis, LifeCheMyriads Space (computational/virtual screening), Compound Library Management (plating, storage, cherry-picking), and Fine Chemicals via subsidiary SynbiaS.
Differentiator
Problem solved
Functional benefit
Brands
- SynbiaS: Fine chemicals for life science and industry - product catalog of 591 compounds
- LifeCheMyriads Space
Products and services
- HTS Compound Collection Comprehensive high-throughput screening compound collection serving as the foundational library for drug discovery screening programs used by pharmaceutical, biotech, and academic researchers.
- Targeted and Focused Screening Libraries Disease-specific and target-specific compound libraries covering 50+ therapeutic areas including ADMET-like (120,000 compounds), Alzheimer's Disease (8,000 small molecules), Parkinson's Disease (18,300+ small molecules), SOS1 Inhibitor (2,600 compounds), Secretase (700 compounds), and Autoimmune Inflammatory Arthritis and Psoriasis (7,800+ compounds).
- Fragment Libraries Fragment-based drug discovery collections including General Fragment Library, 3D-shaped, Fluorine, Covalent, Fsp3-enriched, DSI Poised (2,300 synthetically versatile fragments), and pre-plated fragment screening sets for FBDD applications.
- Covalent Inhibitor Libraries Specialized screening libraries targeting cysteine, histidine, lysine, and serine residues with covalent warheads for irreversible binding in covalent inhibitor discovery programs.
- Building Blocks Chemical building blocks for synthetic chemistry and medicinal chemistry programs, available as stock compounds and synthesized-upon-request options for researchers requiring custom derivatives.
- Pre-plated Screening Sets Assay-ready formatted compounds in 96-, 384-, and 1536-well plate formats including pre-plated diversity sets, focused libraries, and fragment screening sets for immediate high-throughput screening use.
- AI-Generated Screening Compound Sets Novel screening compounds designed using generative AI methods for target-selective compound discovery, including the EGFR AI-enhanced library developed in collaboration with Variational AI for dual EGFR/FGFR1 kinase inhibitor design.
- Custom Synthesis Services Tailored chemical synthesis services including FTE (full-time equivalent) projects, degrader building blocks, DNA-encoded library reagents, and specialized derivatives for pharmaceutical and biotech customers requiring custom chemistry.
- LifeCheMyriads Space Computational chemistry and virtual library service providing billions of ready-to-synthesize molecules for fast, smart drug discovery, enabling virtual screening and analog identification for medicinal chemistry programs.
- Compound Library Management Services Comprehensive compound library management including storage, plating, reformatting, secure storage at -40C, cherry-picking, and customized plate mapping with worldwide distribution capabilities for customer compound collections.
- Fine Chemicals by SynbiaS Specialized fine chemicals catalog from subsidiary SynbiaS comprising 591 compounds for life science research and industrial applications.
- Early Drug Discovery Services Early-stage drug discovery services including computational chemistry, analogue search, and library synthesis for pharmaceutical and biotech customers.
Quantifiable outcome
- Minimum 90% purity confirmed by LCMS and/or 400MHz NMR for all products
- +2 more outcomes
Companies that use Life Chemicals
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles1 record
Life Chemicals technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration18 records
AI capability3 records
Feature3 records
Life Chemicals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Variational AIcoreCollaboration on AI-driven design of novel dual EGFR/FGFR1 kinase inhibitors. Joint poster presented at Discovery on Target 2025 titled 'Discovery of Novel Dual EGFR/FGFR1 Inhibitors via AI-driven Design and Synthesis'. The partnership combines Life Chemicals' compound libraries and synthesis capabilities with Variational AI's generative AI technology for drug discovery.
Scale indicators9 records
Recent moves6 records
Expansion highlights5 records
Life Chemicals competitors and assessment
Company assessmentDirect peers
- Combi-Blocks: Supplier of chemical building blocks and screening libraries for medicinal chemistry. Directly competes with Life Chemicals' Building Blocks product line and focused screening libraries.
- ChemSpace: Online marketplace for screening compounds, building blocks, and fragments with global delivery. Directly comparable product offering and customer base to Life Chemicals' stock catalog.
- eMolecules: Chemical search and procurement platform for screening compounds and building blocks. Comparable as a self-service channel competing with Life Chemicals' e-commerce platform.
- Enamine: Ukraine-based supplier of screening compounds, building blocks, and custom synthesis services with a comparable catalog model including the REAL database of virtual compounds. Direct head-to-head competitor in HTS collections and chemical building blocks.
- MolPort: Chemical sourcing marketplace aggregating compounds from multiple suppliers. Comparable as a competing sales channel for screening compounds and building blocks used in drug discovery.
- Key Organics / Bionet: UK-based supplier of screening compounds, building blocks, and fragment libraries for drug discovery. Directly comparable product mix and target customer base.
- OTAVA Chemicals: Supplier of focused screening libraries and chemical building blocks for drug discovery programs. Comparable in catalog structure and customer segments to Life Chemicals.
- Vitas-M Laboratory: Provider of building blocks, screening compounds, and custom synthesis with comparable catalog and custom chemistry offerings to Life Chemicals.
Broad incumbents
- WuXi AppTec: Global CRO/CDMO with a much broader service portfolio including custom synthesis, compound management, and drug discovery services. Competes with Life Chemicals' contract research arm but at vastly greater scale.
Emerging players
- BioAscent Discovery: CRO offering compound management, logistics, and drug discovery services. Comparable to Life Chemicals' Compound Library Management Services business line serving similar CRO and biotech customers.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Life Chemicals social profiles
Digital presenceLife Chemicals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Life Chemicals leadership team
Management profileNumber of profiles
Life Chemicals subsidiaries and ownership
Company hierarchySubsidiaries1 record
Life Chemicals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Life Chemicals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Life Chemicals
What does Life Chemicals do?
Life Chemicals manufactures and supplies high-throughput screening (HTS) compound collections, targeted screening libraries, fragment libraries, covalent inhibitor libraries, and medicinal chemistry building blocks for drug discovery. The company also provides contract research services including custom synthesis, computational chemistry via its LifeCheMyriads Space platform, and compound library management (plating, storage, cherry-picking, worldwide distribution).
Is Life Chemicals a public or private company?
Life Chemicals is a private company. It is classified as unknown and is currently operating.
When was Life Chemicals founded?
Life Chemicals was founded in 2004. It employs 51 to 100 people.
Where is Life Chemicals based?
Life Chemicals is headquartered in Niagara Falls, Canada, in the North America region.
How does Life Chemicals make money?
Four revenue lines are on record. Screening Compound and Library Sales are the primary driver. The others are building Blocks, compound Library Management Services and custom Synthesis and Contract Research.
Who are Life Chemicals's main competitors?
Direct peers on record are Combi-Blocks, ChemSpace, eMolecules, Enamine, MolPort, Key Organics / Bionet, OTAVA Chemicals and Vitas-M Laboratory. WuXi AppTec is listed as a broad incumbent. BioAscent Discovery is listed as an emerging player.
Does Life Chemicals have an API?
No public API is recorded for Life Chemicals.
What industry is Life Chemicals in?
Life Chemicals's product category is Drug Discovery Screening Compounds and Building Blocks. Its primary akta.pro industry code is HLAAAIAA, High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening), with a secondary code of HLAAAIAL, Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries). Its NAICS code is 54171 and its SIC code is 2833.